BMC Women’s Health (2023) 23:96
Following publication of the original article [1], the text need to be added in the acknowledgement section “Óscar Lourenço, whose affiliation is Univ. Coimbra, CeBER, Faculty of Economics, Av. Dias da Silva 165, 3004 − 512 Coimbra, has participated in the elaboration of this paper and should be considered as an author. He was not included in the author list due to an unnoticed error”. So, the acknowledgement section will read as “The authors would like to acknowledge to the expert panel members who kindly accepted to participate in this work: Dra. Olga Ilheu, Dra. Amélia Pedro, Dr. José Moutinho, Dra. Fernanda Loureiro, Dra. Paula Borralho, and Dra. Ana Quintas. D. Figueiredo acknowledges the support of CIDMA through the Portuguese Foundation for Science and Technology (UIDB/04106/2020). Óscar Lourenço, whose affiliation is Univ. Coimbra, CeBER, Faculty of Economics, Av. Dias da Silva 165, 3004 − 512 Coimbra, has participated in the elaboration of this paper and should be considered as an author. He was not included in the author list due to an unnoticed error.”
The original article has been corrected.
Reference
Figueiredo D, Ribeiro I, Penedones A, et al. Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis. BMC Womens Health. 2023;23:96. https://doi.org/10.1186/s12905-023-02219-0.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12905-023-02219-0.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Figueiredo, D., Ribeiro, I., Penedones, A. et al. Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis. BMC Women's Health 24, 102 (2024). https://doi.org/10.1186/s12905-024-02927-1
Accepted:
Published:
DOI: https://doi.org/10.1186/s12905-024-02927-1